Drug Approval | November 24, 2021
U.S. FDA approves first treatment for drug-resistant post-transplant infection
The approval is for Cytomegalovirus, a type of Herpes virus
The approval is for Cytomegalovirus, a type of Herpes virus
EaseVRx employs the principles of cognitive behavioural therapy and other behavioural therapy techniques for the reduction of pain and pain interference
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
Evidence also shows better immune response to virus among users of spray
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
Acute therapies continue to report strong growth compared to chronic ones.
The test combines sensitivity with speed and is designed to be used in health care settings to aid with rapid diagnosis of Covid-19
The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology
Post normalisation of high growth months of April and May this year the average IPM growth from June to August this year stood at 15.2 % YoY : Ind-Ra reports
Subscribe To Our Newsletter & Stay Updated
